Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001037389-19-000002
Filing Date
2019-02-12
Accepted
2019-02-12 13:52:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 abio-13g_20181231.txt SC 13G 11682
  Complete submission text file 0001037389-19-000002.txt   13440
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 19589767
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 800 THIRD AVE NEW YORK NY 10022
Business Address 800 THIRD AVE NEW YORK NY 10022 2124866780
RENAISSANCE TECHNOLOGIES LLC (Filed by) CIK: 0001037389 (see all company filings)

EIN.: 260385758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G